Dese de alta para crear alertas sobre sus instrumentos,
eventos económicos y autores favoritos
Registrarse gratis ¿Ya tiene cuenta? Iniciar sesión
Cotizaciones
Todos los instrumentos
- Todos los instrumentos
- Índices
- Acciones
- ETFs
- Fondos
- Materias primas
- Divisas
- Cripto
- Bonos
- Certificados
Por favor, inténtelo con una nueva búsqueda
🍎 🍕 ¿Menos 'apples' y más pizzas? 🤔 ¿Ha visto el portafolio de Buffet recientemente?
Explore gratis
Janus Henderson Capital Funds Plc - Global Life Sciences Fund Class A2 Heur (0P00000ITG)
Agregar/Eliminar del portafolio
Agregar a portafolio
44.540
+0.120
+0.27%
20/11 - Mercado cerrado. Valores en EUR
Tipo:
Fondo
Mercado:
Irlanda
Emisor:
Janus Henderson Investors
ISIN:
IE0002122038
Clase de activo:
Acciones
- Rating de Morningstar:
- Total de activos: 4.02B
Janus Henderson Capital Funds plc - Global Life Sc
44.540
+0.120
+0.27%
Panorama 0P00000ITG
En esta página encontrará un perfil detallado de Janus Henderson Capital Funds Plc - Global Life Sciences Fund Class A2 Heur. Conozca la gestión clave, los activos totales, la estrategia de inversión y la información de contacto de 0P00000ITG, entre otros datos.
Información de contacto
Dirección
201 Bishopsgate
London,London EC2M 3AE
United Kingdom
London,London EC2M 3AE
United Kingdom
Telefono
8002270486
Ejecutivos
| Nombre | Título | Desde | Hasta |
|---|---|---|---|
| Daniel Lyons | Portfolio Manager | 2023 | Ahora |
| Biografía | "Daniel Lyons is a Portfolio Manager and Research Analyst at Janus Henderson Investors responsible for co-managing the Biotechnology strategy since 2018. Daniel started consulting for Janus in 1997 and joined the Health Care Sector Research Team full time in 2000. As a research analyst, he focuses on the biotechnology and life science tools sectors. Daniel received his bachelor of arts degree in biochemistry and chemistry from Rice University, graduating magna cum laude. He also earned a PhD from Stanford University’s programme in immunology and conducted postdoctoral research with a Nobel Laureate at the University of Colorado. He holds the Chartered Financial Analyst designation and has 19 years of financial industry experience." | ||
| Andy Acker | Portfolio Manager | 2007 | Ahora |
| Biografía | "Andy Acker is a Portfolio Manager at Janus Henderson Investors responsible for managing the Global Life Sciences and Biotechnology strategies since 2007 and 2018, respectively. He also leads the firm’s Health Care Sector Research Team. Andy was assistant portfolio manager on the Global Life Sciences strategy from 2003 to 2007. He joined Janus in 1999 as a research analyst focused on companies in the biotechnology and pharmaceutical industries. Prior to this, he worked as a strategy consultant for the Boston Consulting Group and as a health care analyst for Morgan Stanley Venture Partners. Andy received his bachelor of science degree in biochemical sciences from Harvard University, graduating magna cum laude and Phi Beta Kappa. He also earned an MBA with honours from Harvard Business School. Andy holds the Chartered Financial Analyst designation and has 23 years of financial industry experience." | ||
| Ethan Lovell | Portfolio Manager | 2015 | 2022 |
| Biografía | Ethan Lovell is a Portfolio Manager at Janus Henderson Investors, responsible for co-managing the Global Life Sciences strategy, a position he has held since 2016. Prior to this, Mr. Lovell served as assistant portfolio manager on the strategy. He is also a Research Analyst, primarily focusing on the global pharmaceutical and medical device industries. Before joining Janus in 2007 as a research analyst, Mr. Lovell was a director at ClearBridge Advisors, covering companies in the pharmaceutical, biotechnology and medical device industries. Previously, he was managing director and founding partner of Saranac Capital, LP, where he was the health care sector portfolio manager. Mr. Lovell also worked at Salomon Brothers Asset Management as a director and later managing director of the health care team. He began his career at Bear, Stearns & Co. as an equity research analyst covering biotechnology, pharmaceuticals and life science tool companies. Mr. Lovell received his bachelor of arts degree, with a double major in chemistry and economics, from Bowdoin College and his MBA from Tulane University. He has 24 years of financial industry experience. Ethan Lovell is a Portfolio Manager at Janus Henderson Investors, responsible for co-managing the Global Life Sciences strategy, a position he has held since 2016. Prior to this, Mr. Lovell served as assistant portfolio manager on the strategy. He is also a Research Analyst, primarily focusing on the global pharmaceutical and medical device industries. Before joining Janus in 2007 as a research analyst, Mr. Lovell was a director at ClearBridge Advisors, covering companies in the pharmaceutical, biotechnology and medical device industries. Previously, he was managing director and founding partner of Saranac Capital, LP, where he was the health care sector portfolio manager. Mr. Lovell also worked at Salomon Brothers Asset Management as a director and later managing director of the health care team. He began his career at Bear, Stearns & Co. as an equity research analyst covering biotechnology, pharmaceuticals and life science tool companies. Mr. Lovell received his bachelor of arts degree, with a double major in chemistry and economics, from Bowdoin College and his MBA from Tulane University. He has 24 years of financial industry experience. Mr. Lovell received his bachelor of arts degree, with a double major in chemistry and economics, from Bowdoin College and his MBA from Tulane University. | ||
| Thomas R. Malley | Portfolio Manager | 2000 | 2007 |
| Biografía | Malley joined Janus Capital Corporation in 1991 and currently serves as a portfolio manager. Malley holds the Chartered Financial Analyst designation. | ||
Escribe tus pensamientos respecto al Janus Henderson Capital Funds Plc - Global Life Sciences Fund Class A2 Heur
¿Estás seguro que quieres borrar este gráfico?
Eliminar Cancelar
¿Sustituir el gráfico adjunto por un nuevo gráfico?
Sustituir Cancelar
Guía para comentarios
Adjuntar un gráfico al comentario
Confirmar bloqueo
¿Está seguro de que desea bloquear a %USER_NAME%?
Al hacerlo, ni usted ni %USER_NAME% podrán ver las publicaciones del otro en Investing.com.
Se ha agregado correctamente a %USER_NAME% a su lista de usuarios bloqueados
Acaba de desbloquear a esta persona; tiene que esperar 48 horas para poder bloquearla de nuevo.
Denunciar este comentario
Díganos qué piensa de este comentario
Comentario denunciado
Gracias
Su denuncia será examinada por nuestros moderadores